219 related articles for article (PubMed ID: 29232521)
1. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
[TBL] [Abstract][Full Text] [Related]
3. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.
Teesalu T; Sugahara KN; Kotamraju VR; Ruoslahti E
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16157-62. PubMed ID: 19805273
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
[TBL] [Abstract][Full Text] [Related]
5. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
Jung K; Kim JA; Kim YJ; Lee HW; Kim CH; Haam S; Kim YS
Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
[TBL] [Abstract][Full Text] [Related]
6. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
7. Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.
Zhao L; Chen H; Lu L; Zhao C; Malichewe CV; Wang L; Guo X; Zhang X
Life Sci; 2021 Apr; 270():119113. PubMed ID: 33508290
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
Glinka Y; Prud'homme GJ
J Leukoc Biol; 2008 Jul; 84(1):302-10. PubMed ID: 18436584
[TBL] [Abstract][Full Text] [Related]
9. Transtumoral targeting enabled by a novel neuropilin-binding peptide.
Roth L; Agemy L; Kotamraju VR; Braun G; Teesalu T; Sugahara KN; Hamzah J; Ruoslahti E
Oncogene; 2012 Aug; 31(33):3754-63. PubMed ID: 22179825
[TBL] [Abstract][Full Text] [Related]
10. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.
Kadonosono T; Yamano A; Goto T; Tsubaki T; Niibori M; Kuchimaru T; Kizaka-Kondoh S
J Control Release; 2015 Mar; 201():14-21. PubMed ID: 25592386
[TBL] [Abstract][Full Text] [Related]
11. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.
Fantin A; Herzog B; Mahmoud M; Yamaji M; Plein A; Denti L; Ruhrberg C; Zachary I
Development; 2014 Feb; 141(3):556-62. PubMed ID: 24401374
[TBL] [Abstract][Full Text] [Related]
13. Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa.
Pemmari T; Ivanova L; May U; Lingasamy P; Tobi A; Pasternack A; Prince S; Ritvos O; Makkapati S; Teesalu T; Cairo MS; Järvinen TAH; Liao Y
Mol Ther; 2020 Aug; 28(8):1833-1845. PubMed ID: 32497513
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells.
Valdembri D; Caswell PT; Anderson KI; Schwarz JP; König I; Astanina E; Caccavari F; Norman JC; Humphries MJ; Bussolino F; Serini G
PLoS Biol; 2009 Jan; 7(1):e25. PubMed ID: 19175293
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 Acts as a Receptor for Complement Split Products.
Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
Front Immunol; 2019; 10():2209. PubMed ID: 31572401
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability.
Plein A; Fantin A; Ruhrberg C
Microcirculation; 2014 May; 21(4):315-23. PubMed ID: 24521511
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.
Kawamura H; Li X; Goishi K; van Meeteren LA; Jakobsson L; Cébe-Suarez S; Shimizu A; Edholm D; Ballmer-Hofer K; Kjellén L; Klagsbrun M; Claesson-Welsh L
Blood; 2008 Nov; 112(9):3638-49. PubMed ID: 18664627
[TBL] [Abstract][Full Text] [Related]
18. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine.
Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.
Akatsu Y; Yoshimatsu Y; Tomizawa T; Takahashi K; Katsura A; Miyazono K; Watabe T
Cancer Sci; 2017 Jan; 108(1):151-155. PubMed ID: 28133920
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.
Parker MW; Xu P; Li X; Vander Kooi CW
J Biol Chem; 2012 Mar; 287(14):11082-9. PubMed ID: 22318724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
